isolates. MRSA and methicillin-susceptible S. aureus were resistant to trimethoprim/ sulfamethoxazole, a commonly used drug at UTH. S. pneumoniae was resistant to most drugs against which it was tested.
Spectrum of Respiratory Pathogens Detected by Multiplex PCR in a Study of Respiratory Tract Infections Among Travelers
Methods. Prospectively collected 63 respiratory specimens (sputum or throat swab) from patients presented with respiratory symptoms (cough, sputum, chest pain, dyspnea, tachypnea, or abnormal findings of chest auscultation) after travel were tested using multiplex real-time PCR. The FTD Respiratory pathogens 33 (Fasttrack diagnostics, Ltd.) can simultaneously detect 33 different respiratory pathogens directly from respiratory specimens. This test ran in the PCR-Only mode on BD MAX™ (Nippon Becton Dickinson Company, Ltd.) and LightCycler480 System (Roche).
Results. Fifty-nine consecutive cases were included in the study. Thirty-nine cases were diagnosed as non-specific upper respiratory tract infections, five cases were influenza, bronchitis, pneumonia, threecases was acute sinusitis, and one case was acute pharyngitis, dengue fever. Twenty-four cases had returned from travel in Southeast Asia, nine from Africa, and 8 from Latin America, seven from South Asia, six from middle east, threefrom North America, threefrom East Asia, 2 from Oceania, and one from Europe. Of the 59 specimens analyzed, 48 (81.4%) tested positive for pathogens whereas 11 tested negative. Commonly detected pathogens were Haemophilus influenzae (14 cases; 23.7%), influenza A (10 cases; 17.0%), rhinovirus (9 cases; 15.2%), Staphylococcus aureus (8 cases; 13.6%), Moraxella catarrhalis (8 cases; 13.6%), Streptococcus pneumonia, coronaviruses OC43, and Mycoplasma pneumoniae (4 cases; 6.8%, respectively). Multiple pathogens were detected in 30.5% of the specimens. In 14 cases (23.7%), both virus and bacteria were detected from one specimen.
Conclusion. Not only viruses, bacterial pathogens were detected frequently than expected in the patients of RTI. Comprehensive molecular testing such as multiplex realtime PCR would change our understandings of epidemiology of RTI among travelers. Background. Pre-travel medical consultations attempt to reduce travel-associated risks by behavioral modification, vaccination, and medications. Provider understanding of quantitative risk of commonly discussed travel topics is poorly characterized. We investigated travel medicine provider understanding of quantitative risk of common travel-associated diseases, and explored how providers relay risk estimates to travelers.
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Understanding Travel Medicine Provider's Risk Assessment of Travel-Associated Diseases
Methods. After institutional review board (IRB) approval, an online anonymous survey was sent to the International Society for Travel Medicine Listserv. Travel medicine experience, practice patterns and demographics were recorded. Respondents estimated quantitative risk of various destination-specific diseases. Descriptive statistics were completed.
Results. Of 114 respondents, most were experienced travel medicine providers (79% saw >6 travel visits monthly). Overall risk estimates are in Table 1 . Compared with published literature, providers gave accurate risk estimates for some diseases (yellow fever, traveler's diarrhea), but overestimated quantitative risk for others (Japanese encephalitis, hepatitis A, cholera). Interquartile range was greatest for Japanese encephalitis and cholera, reflecting a wider range of risk estimates. Most (81%) providers used general risk descriptions (high, low, none) and a minority (14%) discussed quantitative risk with travelers.
